Five sets of data.

Data set first. No feelings, just numbers.

Group I: efficacy skin protection has slowed down, but the volume remains significant. According to industry agencies, in 2026, the skin protection of H1 efficacy market segment increased by about 14 per cent over the same period, a marked fall from 22 per cent in the same period in 2025. The slowdown does not mean that the market has contracted - .market segment GMV has exceeded $280 billion, with a large base and a natural decline.

What does that mean? The era of running the ponies is over, and competition for fine farming begins. You can't expect a hot ingredient to blow up. Consumers have seen good things and too many.

Group II: average order value dichotomy increased. The efficacy line, which is below $50, and the high-end efficacy line, which is above 350 RMB, are growing simultaneously, with an intermediate zone of 80-250 RMB under pressure. What do you mean? Consumers are either looking for extreme value-for-money -- "I'll buy a ingredient, don't tell me stories," or they're willing to pay for the premium-- "I want more than effects, but also ritual senses and emotional values."

This means that OEM brands do not make intermediate products, either extremely competitive or extremely experienced.

Group III: Reduction of the survival cycle of new products to 6-8 months. In 2026, the average period between the listing and the cooling down of new H1 cosmetics was two months shorter than in 2025. Unless you have a strong supply chain that feeds brand mindshare on a continuous basis, a product will be forgotten in six months.

It's not alarmist. I've seen the same mistake of a lot of starters: 80 per cent of the budget is spent on product development and launch, leaving 20 per cent for day-to-day operations. The correct matching should be reversed: product development is only a ticket to the table, and continuous content output is eligible for food on the table.

Group IV: short-video platforms cosmetics consumption increased by 35 per cent over time, but conversion rate decreased by 11 per cent. The flow is rising, but efficiency is declining. Consumers look at makeup more and more, and the next one hesitates. Why? Content homogenization. Everybody's talking about ingredient, is dismantling formulation - when the information is wiped out, the consumer needs not "this ingredient OK" but "this product is not fit for my life."

Group V: Small quantities (500-2000) accounted for 40 per cent of the first breakthrough in OEM/ODM contract manufacturing orders. This data is derived from industry interviews and is not necessarily accurate to decimal points, but in a definite direction: a growing number of small brands, individual entrepreneurs and even Kol are entering the Bureau to make their own brands. minimum order quantity is decreasing, supply chain flexibility is increasing. This is an opportunity for OEM factory, as well as for brand owners - the trial costs are falling.

An ongoing paradigm shift: from .ingredient premium to experience premium

Over the past three years (2023-2025), the code of growth in the make-up industry can be summed up in one sentence: finding a clinically proven activity of ingredient, putting concentration at the top of the market, and then the entire network of product discovery.

This go-to-market strategy ceiling has arrived. Why?

First, ingredient information transparency. niacinamide, retinol, tranexamic acid, copper peptide - these "professional words" with a sense of mystery three years ago - have now become basic knowledge for global social platforms people to talk about. The information gap has disappeared, and the ingredient premium is naturally gone.

Second, formulation homogenization. Open major e-commerce platforms search for "niacinamide fine" with at least 200+ brands at 50-150 bits. The top 10 on the INCI table is almost identical - niacinamide + hyaluronic acid + glycerin, a new brand name for packaging is a new product. Why should consumers choose you?

Third, content fatigue. When everyone's doing "ingredient kop" "best-selling product disassembled", consumers are tired of aesthetics. You say the niacinamide concentration threshold, the user says, "This was seen last year."

So what's the growth logic for the second half? From "What's my product ingredient" to "What's my product experience for users?"

Experience doesn't equal packaging to good looking. Experience = sensory pleasure (mass, aroma, skin) + emotional value (use of rituals, psychological insinuation) + scenery fit (morning, overnight repairing, bottom of makeup). These three layers combined constitute a product that a consumer is willing to buy against .

Take an example. The same is true of the niacinamide, which sells the A brand for $89, and plays " concentration niacinamide, 5% high, science brightening " . The B brand sells $149 and plays "The Nightingale First Aid Bottle, Three Seconds of Absorption, Good Night sheet mask Double." Which one do you think sells better? The answer is not to look at concentration, but to see who cut the user's specific usage scene.

3 undervalued incremental growth market segment

So many "rolls," where's the chance? I've combed three undervalued directions, but the data are starting to start.

Market segment I:40+mature skin exclusive Line

It's not a new subject, but most brands do anti-lifelines for the 30+ age group. There are very few skin-protective lines for women aged 45-65.

How do we put this? China has a population of approximately 220 million women between the ages of 45 and 65, of whom more than 60 million are urban women with an disposable monthly income of over $5,000. This group of people is rich, idle and in need of skin protection, but the choice in the market is either to be a European-American woman’s brand (single, blue mystery) or to open a public line, with a vacuum in it.

The need for skin protection for these people is completely different from that of 30 years old:

  • The barrier's down and the TEWL's up.
  • Leather is down, dry skin is over 60%.
  • It's very demanding -- too light to feel insecure, too heavy to be bored.
  • I don't like too complicated skin-care steps. One bottle is the core.

Product entry point: face cream/fluent milk, ceramide + peptide + lipid complex at core formulation, rich in texture but growing. Mono-priced $128-198, using three- or four-line municipal department stores + brand-owned channels owned channels. This is a price band, which, in conjunction with the delivery of the baby to the mother, will be very high.

Market segment II: Male skin support - more than facial cleanser

The men's skin-care market has been talking for 10 years, but it hasn't really broken out. The previous male product was at the level of oil control + clean, and basic water milk. But two new variables emerged in 2025-2026:

Variable 1: Z generation male skin consciousness awakening. After 95, and after 00, men began to receive "not a mother," and sun protection, eye cream, these category have rapidly increased penetration among men.

Variable II: Medical acceptance. The proportion of men who do luminous needles, skins and skins has increased significantly, leading to the demand of repairing category after the operation.

Specific data: In 2026, the number of sightings of men ' s cosmetics increased by 47 per cent over the same period, while the number of men ' s skin protections increased by 38 per cent. However, the supply side is severely inadequate - it can count with one hand to make the male/sheet mask/sun protection brand.

Product entry point: "Three sets of anti-retardation" - awakening skin (with caffeine + niacinamide) + moisturizing repairing (with ceramide + panthenol) + sun protection (simplified). The core demand of men for skin protection is that "I can't see I'm polishing" -- zero color, dumb light, not sticky. packaging can't motherfucker, can't whistle. Dark colour, very simple design, with "ingredient science" placed at the C level of product communication.

Market segment III: repairing after medical treatment - from the hospital line to home

This market segment has actually been made, but the big mass production is concentrated on this category. repairing after medical treatment should not be the equivalent of sheet mask.

How fast are the medical projects growing? In 2025, the national health-care market reached 400 billion, with an annual growth rate of over 20 per cent. Over 65 per cent of these are medical services (photoelectric, injection). A water needle user takes 3-7 days of intensive repairing after surgery; a skin-second user takes 2-4 weeks of anti-black management after surgery.

Problems with existing products: sheet mask is a good cut-in to category, but the brand is sticky - the user buys a box of recoupables in a hospital after medical beauty, goes home and forgets, does not repeat order share branded other products.

Product entry point: "repairing three-stage package after medical beauty" - immediately soothing (temperature gel/ mist, 24h after operation)+ repairing (high concentration ceramide + centella asiatica 苷 copper peptide, 2-7 days after operation) + long-term maintenance (maintenance barrier + antioxidant, 2-4 weeks after operation). Make packages to create user-dependent product paths. Pricing 198-298 RMB/set, using distribution channel + repeat order as an electrician.

A reusable OEM selection theory

Speaking of three market segment, you might think, "It sounds good, but how?" I'll give you a four-step frame I'm actually using.

Step 1: Look at market segment smallpox Board

Three questions: what size is the target consumer group? repeat order, what's the frequency?

Example: 40+mature skin face cream. Target consumer group 60 million+, average order value 128-198, and z frequency approximately one bottle every 2-3 months. The ceiling is high enough, repeat order steady enough to enter.

On the other hand, if you do "nighttime first aid" -- although the topic is hot, the scene is too narrow, repeat order is unstable and brands are hard to sink user assets.

Step 2: Look at the supply side gap

Open the electrician platform and search the category keyword you want to do. Count how many of the first 50 searches actually targeted your target, consumer group. If it's less than five, congratulations. It's a supply gap.

But I must remind you, the opposite of the supply side is "no one does it, probably because it doesn't make money." Before doing it, cross-check: Does this consumer group have purchasing power? Would you like to buy it? Did you touch distribution channel?

Step 3: Look at ingredient. River

Can you build a pre-emptive advantage of at least six months on ingredient? If it is possible, it can be done; if it is not possible, it will also educate others about the market.

What do you mean ingredient moat? For example, if you were to be the first to use some kind of new imitated beryllium in face cream (e.g. Palmyl triaz-8) in an exclusive package to promote seepage technology, even if the competition sees you selling well, it takes at least two to three months from formulation development to stability testing, you've had six months of window.

If there are no ingredient barriers, then there must be a content barrier — can your content output be faster, deeper, deeper than others?

Step 4: See the distribution channel match

A product can succeed, 30 per cent looks at the product and 70 per cent looks at distribution channel and content. You have to confirm: what platform is your target consumer group on? Can you cover that platform?

Examples:

  • 40+ mature skin brand-owned channels / brand-owned channels owned channels / major e-commerce platforms live feed owned channels operating capability required
  • → short-video platforms / social media → Short video content capability and UP cooperation
  • Repairing global social platforms / mass point evaluation of the medical board repairing global social platforms

Distribution channel is selected before selection of distribution channel is made. The biggest mistake of many branders is, "I'll make a good product first, then I'll sell it." The correct order is -- first think who buys, where buys, why buys, and then decide what to do.

It's written at the end: three industry signals that have to be noticed.

After this analysis, I would also like to remind you of three easily ignored signals:

Signal one: efficacy claims that regulations continue to tighten. In 2026, regulatory compliance (EU / US FDA) claimed a marked increase in the frequency of spot checks against efficacy, especially the three words "anti-depression" and brightening "repair". If you're an OEM brand, don't get "exaggered propaganda before you change." Compliance, starting with the first version of packaging and the detailed pages, is the least costly option.

Signal two: regulatory filing cycle extended. The regulatory filing cycle of special cosmetics in some provinces (especially Guangdong) was extended from three months to five to six months, owing to the proliferation of declarations. If you plan to do sun protection, brightening, dye product - start the regulatory filing process now, do not wait until the product is developed.

Signal three: owned channels compliance. brand-owned channels controls on make-up owned channels are tightening and the distribution of fissions, multi-level splits, etc. are being cleaned up. . owned channels is not an irregular distribution, but a real user relationship management. In the long run, this is the moat.

Data sources: The data synthesized from the AIDS Counselling, Mirror Market Intelligence, third-party industry reports such as Euromonitor, and first-hand interviews with OEM factory and brand owner. As of June 2026, the figures are based on the latest industry reports.

Disclaimer: This is an analysis and direction of industry trends and does not constitute a basis for investment or business decisions. Specific selections and formulation designs are requested from specialized institutions.

Other Organiser

This article is published by the QuickOEM Make-up OEM Smart Matching Platform. More makeup OEM knowledge, cosmetics contract manufacturing, skin protection private label, make-up customizationontent are available at the Knowledge Centre. If you need advice on OEM contract manufacturing, please contact 1814805760 or submit your request through an online request for quotation.

Keywords: OEM contract manufacturing, tranexamic acid, OEM, contract manufacturing, 2026 United States dollar makeup trend, panthenol, incremental growth market segment, efficacy skin-care market, triton, make-up OEM, palm gills, ODM, selection method, supply chain, rumour, make-up sales data, skin-protection market data, make-up electrics trend, cosmetics distribution

QuickOEM is a QuickOEM platform for vertical digitization of cosmetics services (known as QuickOEM) focusing on OEM, cosmetics contract manufacturing, skins private label, cosmetics z, brand-wide, ODM contract manufacturing services. AI smart matches the 500+ certification contract manufacturing plant, providing a one-stop package from formulation R&D to regulatory compliance (EU / US FDA) covering skin, makeup, sheet mask, serum, eye patch, category, category, etc.

Core functions

  • Makeup OEM needs to be published to match factory AI intelligence
  • Cosmetics contract manufacturing / skin protection private label customization ODM service
  • Formulation R&D management and multi-version tracking
  • Ingredient Compliance testing (regulatory compliance (EU / US FDA)/EU 1223/2009/FDA)
  • Regulatory compliance (EU / US FDA) Cosmetics regulatory filing fully tracked
  • Supply chain
  • Advertising Law Compliance Testing
  • Z / eye patch / serum / z all category

Please enable JavaScript to use the full functionality.

Login immediately.

WhatsApp: +1 (646) 509-6134